Currently out of the existing stock ratings of Katherine Breedis, 5 are a BUY (100%).

Katherine Breedis

Work Performance Price Targets & Ratings Chart

Analyst Katherine Breedis, carries an average stock price target met ratio of 50% that have a potential upside of 40.48% achieved within 1465 days. Previously, Katherine Breedis worked at STIFEL.

Katherine Breedis’s has documented 10 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on VYGR, Voyager Therapeutics at 27-Jul-2017.

Wall Street Analyst Katherine Breedis

Analyst best performing recommendations are on GILD (GILEAD SCIENCES).

Average potential price target upside

GILD Gilead Sciences VYGR Voyager Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$135

$12.19 (9.93%)

$125

15 days ago
(07-Oct-2025)

15/17 (88.24%)

$16.75 (14.16%)

1220

Buy

$145

$22.19 (18.07%)

$130

1 months 7 days ago
(15-Sep-2025)

4/6 (66.67%)

$34.14 (30.80%)

164

Buy

$133

$10.19 (8.30%)

2 months 28 days ago
(24-Jul-2025)

0/1 (0%)

$17.6 (15.25%)

Hold

$95

$-27.81 (-22.64%)

$89

4 months 12 days ago
(10-Jun-2025)

65/76 (85.53%)

$-12.78 (-11.86%)

1689

Buy

$117

$-5.81 (-4.73%)

$100

5 months 18 days ago
(04-May-2025)

13/13 (100%)

$15.62 (15.41%)

991

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Katherine Breedis?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?